4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-034422
Chief Commercial Officer sold 761 shares at $14.55 ($11,073)
From the SEC's structured data for this filing
Trades in this filing
Yarema Kristin · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-18 | Sale : show line 1 in the form | −761 | $14.55 | $11,073 | 91,528 | D |
| Open-market sales · 761 sh · avg $14.55 · $11,073 | ||||||
Loading xslF345X03/doc4.xml…